These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26392127)

  • 21. Hookah Tobacco Smoking During the Transition to College: Prevalence of Other Substance Use and Predictors of Initiation.
    Shepardson RL; Hustad JT
    Nicotine Tob Res; 2016 May; 18(5):763-9. PubMed ID: 26259986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tobacco smoking among people living with a psychotic illness: the second Australian Survey of Psychosis.
    Cooper J; Mancuso SG; Borland R; Slade T; Galletly C; Castle D
    Aust N Z J Psychiatry; 2012 Sep; 46(9):851-63. PubMed ID: 22645396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sexual identity and prevalence of alcohol and other drug use among Australians in the general population.
    Roxburgh A; Lea T; de Wit J; Degenhardt L
    Int J Drug Policy; 2016 Feb; 28():76-82. PubMed ID: 26691433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary care-relevant interventions for tobacco use prevention and cessation in children and adolescents: a systematic evidence review for the U.S. Preventive Services Task Force.
    Patnode CD; O'Connor E; Whitlock EP; Perdue LA; Soh C; Hollis J
    Ann Intern Med; 2013 Feb; 158(4):253-60. PubMed ID: 23229625
    [TBL] [Abstract][Full Text] [Related]  

  • 25. School-based programmes for preventing smoking.
    Thomas R; Perera R
    Cochrane Database Syst Rev; 2006 Jul; (3):CD001293. PubMed ID: 16855966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Retrospective Analysis of the Outcomes of Smoking Cessation Pharmacotherapy Among Persons With Mental Health and Substance Use Disorders.
    Okoli CT; Anand V; Khara M
    J Dual Diagn; 2017; 13(1):21-28. PubMed ID: 28166473
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
    Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
    Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tobacco Use Among People Incarcerated in Western Europe: A Systematic Review and Meta-analysis.
    Alokan DS; Kabir Z
    Tob Use Insights; 2022; 15():1179173X221096641. PubMed ID: 35600560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addressing tobacco use through organizational change: a case study of an addiction treatment organization.
    Ziedonis DM; Zammarelli L; Seward G; Oliver K; Guydish J; Hobart M; Meltzer B
    J Psychoactive Drugs; 2007 Dec; 39(4):451-9. PubMed ID: 18303702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The key scientific issue of the next century: the science of addiction.
    Hirayama T
    Ann N Y Acad Sci; 1990; 610():115-7. PubMed ID: 2248467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pleasure, addiction, and habit: factors in verbal report of factors in smoking behavior?
    Leventhal H; Avis N
    J Abnorm Psychol; 1976 Oct; 85(5):478-88. PubMed ID: 965576
    [No Abstract]   [Full Text] [Related]  

  • 32. Empirically supported drug treatment for all: Helping a nation get "Clean".
    Flentje A; Sorensen JL
    Psyccritiques; 2013; 58(45):. PubMed ID: 24976802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Additional behavioural support as an adjunct to pharmacotherapy for smoking cessation.
    Stead LF; Koilpillai P; Lancaster T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009670. PubMed ID: 26457723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Will chronic e-cigarette use cause lung disease?
    Rowell TR; Tarran R
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1398-409. PubMed ID: 26408554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nicotine delivery, retention and pharmacokinetics from various electronic cigarettes.
    St Helen G; Havel C; Dempsey DA; Jacob P; Benowitz NL
    Addiction; 2016 Mar; 111(3):535-44. PubMed ID: 26430813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does reduced smoking if you can't stop make any difference?
    Begh R; Lindson-Hawley N; Aveyard P
    BMC Med; 2015 Oct; 13():257. PubMed ID: 26456865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should academic journals publish e-cigarette research linked to tobacco companies?
    Shaw DM; Etter JF; Elger BS
    Addiction; 2016 Aug; 111(8):1328-32. PubMed ID: 26412439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Use of Virtual Reality in the Production of Cue-Specific Craving for Cigarettes: A Meta-Analysis.
    Pericot-Valverde I; Germeroth LJ; Tiffany ST
    Nicotine Tob Res; 2016 May; 18(5):538-46. PubMed ID: 26453669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of e-cigarette visual appearance on craving and withdrawal symptoms in abstinent smokers.
    Dawkins L; Munafò M; Christoforou G; Olumegbon N; Soar K
    Psychol Addict Behav; 2016 Feb; 30(1):101-5. PubMed ID: 26415054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Genome-Wide Association Study of a Biomarker of Nicotine Metabolism.
    Loukola A; Buchwald J; Gupta R; Palviainen T; Hällfors J; Tikkanen E; Korhonen T; Ollikainen M; Sarin AP; Ripatti S; Lehtimäki T; Raitakari O; Salomaa V; Rose RJ; Tyndale RF; Kaprio J
    PLoS Genet; 2015; 11(9):e1005498. PubMed ID: 26407342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.